1
Clinical Trials associated with BI-3821001 / Not yet recruitingPhase 1 A Phase I Single-blind, Randomised, Placebo-controlled, Parallel Group Design Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BI 3821001 Administered to Healthy Trial Participants
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 in healthy male trial participants.
100 Clinical Results associated with BI-3821001
100 Translational Medicine associated with BI-3821001
100 Patents (Medical) associated with BI-3821001
100 Deals associated with BI-3821001